Background: Combining PET amyloid-Î² (AÎ²) and tau imaging may be critical for tracking disease progression in Alzheimer's disease (AD). Objective:We sought to characterize the relationship betweenAÎ² and tau ligands as well as with other measures of pathology. Methods: We conducted a multi-center observational study in early AD (MMSE > 20) participants aged 50 to 85 y. The schedule included cognitive assessments (ADAS-Cog) and CSF measurement of A- and tau at baseline and 6 months; PET-CT imaging with AÎ² ([18F]AV45) and tau ([18F]AV1451) ligands at baseline. Results: 22 participants took part in the study with 20 completing its 6-month duration and 12 having both tau and amyloid PET. The PET biomarker analysis revealed a strong negative correlation between age and tau in multiple regions. Entorhinal cortex tau and age interacted significantly in terms of cognitive change over 6 months which may have been to older participants deteriorating faster despite lower levels of cortical tau. Cortical AÎ² associated with entorhinal cortex tau while CSF tau/AÎ² ratio correlated strongly with cortical tau but not AÎ² Conclusion: The negative relationship between age and cortical tau whereby younger patients with mild AD had relatively greater tau burden is potentially important. It suggests that younger-age onset AD may be primarily driven by tau pathology while AD developing later may depend on a multitude of pathological mechanisms. These data also suggest that PET-tau performs better than PET-amyloid in predicting the best validated AD diagnostic marker'the CSF total tau/AÎ² ratio.
|Data di pubblicazione:||2017|
|Titolo:||PET tau and amyloid-Î² burden in mild Alzheimer's disease: Divergent relationship with age, cognition, and cerebrospinal fluid biomarkers|
|Autore/i:||Koychev, Ivan; Gunn, Roger N.; Firouzian, Azadeh; Lawson, Jennifer; Zamboni, Giovanna; Ridha, Basil; Sahakian, Barbara J.; Rowe, James B.; Thomas, Alan; Rochester, Lynn; Ffytche, Dominic; Howard, Robert; Zetterberg, Henrik; Mackay, Clare; Lovestone, Simon|
|Digital Object Identifier (DOI):||10.3233/JAD-170129|
|Codice identificativo ISI:||WOS:000408582800023|
|Codice identificativo Scopus:||2-s2.0-85028697238|
|Codice identificativo Pubmed:||28800330|
|Citazione:||PET tau and amyloid-Î² burden in mild Alzheimer's disease: Divergent relationship with age, cognition, and cerebrospinal fluid biomarkers / Koychev, Ivan; Gunn, Roger N.; Firouzian, Azadeh; Lawson, Jennifer; Zamboni, Giovanna; Ridha, Basil; Sahakian, Barbara J.; Rowe, James B.; Thomas, Alan; Rochester, Lynn; Ffytche, Dominic; Howard, Robert; Zetterberg, Henrik; Mackay, Clare; Lovestone, Simon. - In: JOURNAL OF ALZHEIMER'S DISEASE. - ISSN 1387-2877. - 60:1(2017), pp. 283-293.|
|Tipologia||Articolo su rivista|
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris